Tempest Therapeutics, Inc. is a biotechnology company based in South San Francisco, California, focused on developing innovative therapies for cancer treatment. The company specializes in harnessing the power of the immune system to create novel therapeutics that target various cancer types. Tempest is dedicated to advancing its research in immuno-oncology, aiming to improve patient outcomes through cutting-edge science and technology. Its commitment to transformative cancer therapies positions it as a key player in the evolving landscape of oncology treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#105 in South San Francisco, CA

#7,118 in California

#29,882 in US

#56,092 in the World

South San Francisco, CA, United States of America

Tempest Therapeutics, Inc.

Forward Citations = 11

16 inventors:

Austin Chih-Yu Chen (10 out of 16 patents)

Yalda Mostofi Bravo (10 out of 20 patents)

Joe Fred Nagamizo (7 out of 7 patents)

4. Robert Gomez (4 out of 9 patents)

5. Renata Marcella Oballa (4 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tempest Therapeutics, Inc.. Retrieved from https://idiyas.com/company/tempest-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]